Network-Supported Intellectual Property Committee
Network-Supported Intellectual Property Committee
Chair: Diana Royce, EdD
Managing Director and COO, AllerGen NCE Inc.
Judah Denburg, MD, FRCP(C)
Scientific Director and CEO, AllerGen NCE Inc.
Terry Delovitch, PhD
Professor Emeritus, Department of Microbiology & Immunology, University of Western Ontario
Dean Befus, PhD
Professor, Department of Medicine, University of Alberta
Mr. Thierry Bourgeois
Director, University-Industry Liaison Office, Université Laval
Dr. Kevin Fehr, PhD
Consultant, Kincora Innovations
Brian Underdown, PhD
Managing Director, Lumira Capital
Dr. Randall Yatscoff,
Executive Vice-President, TEC Edmonton
Dr. Arlene Yee,
Director, Industry Partnerships and Commercialization, Corporate Ventures, Hospital for Sick Children
Mandate of the Network-Supported Intellectual Property Committee
The Network-Supported Intellectual Property Committee is an advisory standing committee to the Research Management Committee. The NSIP Committee is expected to undertake a detailed review of AllerGen's knowledge and technology exchange and exploitation (KTEE) strategies, plans, opportunities and initiatives, and provide advice to members of the Research Management Committee to identify opportunities relevant to social and/or economic benefit to Canada.